Sandeep Arora

Sandeep Arora


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
RMRashita Makker
Rashita Makker
Tapan BehlTapan Behl
Tapan Behl
Simona BungăuSimona Bungău
Simona Bungău
Gökhan ZenginGökhan Zengin
Gökhan Zengin
VMVineet Mehta
Vineet Mehta
Roxana OanceaRoxana Oancea
Roxana Oancea
Neurological diseases are one of the major healthcare issues worldwide. Posed lifestyle changes are associated with drastically increased risk of chronic illness and diseases, posing a substantial healthcare and financial burden to society globally. Researchers aim to provide fine treatment for ailing disorders with minimal exposed side effects. In recent decades, several studies on functional foods have been initiated to obtain foods that have fewer side effects and increased therapeutic activity. Hence, an attempt has been made to unravel several extraction techniques to acquire essential bioactive compounds or phytochemicals from therapeutically active food products. This has led to the conception of the term functional foods being meddled with other similar terms like “pharmafoods,” “medifoods”, “vitafoods”, or “medicinal foods”. With a dire need to adhere towards healthy options, the demand of nutraceuticals is widely increasing to combat neurological interventions. An association between food habits and the individual lifestyle with neurodegeneration has been manifested, thereby proposing the role of nutraceuticals as prophylactic treatment for neurological interventions. The current review covers some of the major neurological disorders and nutraceutical therapy in the prevention of disease.

19 April 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Tapan BehlTapan Behl
Tapan Behl
Gabriele RocchettiGabriele Rocchetti
Gabriele Rocchetti
SCSwati Chadha
Swati Chadha
Gökhan ZenginGökhan Zengin
Gökhan Zengin
Simona BungăuSimona Bungău
Simona Bungău
Domenico MontesanoDomenico Montesano
Domenico Montesano
To date, the leading causes of mortality and morbidity worldwide include viral infections, such as Ebola, influenza virus, acquired immunodeficiency syndrome (AIDS), severe acute respiratory syndrome (SARS) and recently COVID-19 disease, caused by the SARS-CoV-2 virus. Currently, we can count on a narrow range of antiviral drugs, especially older generation ones like ribavirin and interferon which are effective against viruses in vitro but can often be ineffective in patients. In addition to these, we have antiviral agents for the treatment of herpes virus, influenza virus, HIV and hepatitis virus. Recently, drugs used in the past especially against ebolavirus, such as remdesivir and favipiravir, have been considered for the treatment of COVID-19 disease. However, even if these drugs represent important tools against viral diseases, they are certainly not sufficient to defend us from the multitude of viruses present in the environment. This represents a huge problem, especially considering the unprecedented global threat due to the advancement of COVID-19, which represents a potential risk to the health and life of millions of people. The demand, therefore, for new and effective antiviral drugs is very high. This review focuses on three fundamental points: (1) presents the main threats to human health, reviewing the most widespread viral diseases in the world, thus describing the scenario caused by the disease in question each time and evaluating the specific therapeutic remedies currently available. (2) It comprehensively describes main phytochemical classes, in particular from plant foods, with proven antiviral activities, the viruses potentially treated with the described phytochemicals. (3) Consideration of the various applications of drug delivery systems in order to improve the bioavailability of these compounds or extracts. A PRISMA flow diagram was used for the inclusion of the works. Taking into consideration the recent dramatic events caused by COVID-19 pandemic, the cry of alarm that denounces critical need for new antiviral drugs is extremely strong. For these reasons, a continuous systematic exploration of plant foods and their phytochemicals is necessary for the development of new antiviral agents capable of saving lives and improving their well-being.

22 November 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SSSukhbir Singh
Sukhbir Singh
NSNeelam Sharma
Neelam Sharma
Tapan BehlTapan Behl
Tapan Behl
BSBidhan Chandra Sarkar
Bidhan Chandra Sarkar
HSHasi Rani Saha
Hasi Rani Saha
Md. Sohanur RahmanMd. Sohanur Rahman
Md. Sohanur Rahman
Psoriasis is a chronic inflammatory autoimmune disorder that moderately affects social and interpersonal relationships. Conventional treatments for psoriasis have certain problems, such as poor drug penetration through the skin, hyper-pigmentation, and a burning sensation on normal and diseased skin. Colloidal drug delivery systems overcome the pitfalls of conventional approaches for psoriasis therapeutics and have improved patient safety parameters, compliance, and superior effectiveness. They also entail reduced toxicity. This comprehensive review’s topics include the pathogenesis of psoriasis, causes and types of psoriasis, conventional treatment alternatives for psoriasis, the need for colloidal drug delivery systems, and recent studies in colloidal drug delivery systems for the treatment of psoriasis. This review briefly describes colloidal drug delivery approaches, such as emulsion systems—i.e., multiple emulsion, microemulsion, and nano-emulsion; vesicular systems—i.e., liposomes, ethosomes, noisomes, and transferosomes; and particulate systems—i.e., solid lipid nanoparticles, solid lipid microparticles, nano-structured lipid carriers, dendrimers, nanocrystals, polymeric nanoparticles, and gold nanoparticles. The review was compiled through an extensive search of the literature through the PubMed, Google Scholar, and ScienceDirect databases. A survey of literature revealed seven formulations based upon emulsion systems, six vesicular drug delivery systems, and fourteen particulate systems reported for antipsoriatic drugs. Based on the literature studies of colloidal approaches for psoriasis management carried out in recent years, it has been concluded that colloidal pharmaceutical formulations could be investigated broadly and have a broad scope for effective management of many skin disorders in the coming decades.

1 July 2021 in Inflammation Research
Verified
Journal Article
Closed access
PDF file
MGManisha Gupta
Manisha Gupta
PKPawan Krishan
Pawan Krishan
AGAmarjot Kaur Grewal
Amarjot Kaur Grewal
SASandeep Arora
Sandeep Arora
NTNirupma Trehanpati
Nirupma Trehanpati
OBOnkar Bedi
Onkar Bedi

28 February 2023 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
VSVandana Saini
Vandana Saini
RBRajni Bala
Rajni Bala
SASandeep Arora
Sandeep Arora
Andrographis paniculata is widely used plant in Southeast Asia, China and India as a healthy food, it contains andrographolide as a pharmacologically active constituent isolated from leaves and roots of Andrographis paniculata and has got wide therapeutic potential including anti-inflammatory, antiviral and hepatoprotective activity but its bioavailability is limited due to its poor solubility, rapid clearance rate and high plasma protein binding. Several attempts involving formulation of liposomes, noisome, nanoparticles, micro emulsions and solid lipid nanoparticle have been done to perk up its solubility and hence bioavailability. The aim of the proposed work is to formulate Phytosomes of methanolic extract of leaves of Andrographis paniculate. The Phytosomes were formulated using thin film hydration technique with varying molar ratios of phospholipid and extract of leaves of Andrographis paniculate. Formulated Phytosomes were characterized for particle size and size distribution, entrapment efficiency, in-vitro drug release characteristics, scanning electron microscopy and FTIR analysis.

1 February 2022 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Rajwinder KaurRajwinder Kaur
Rajwinder Kaur
GCGaurav Chaudhary
Gaurav Chaudhary
AKAmritpal Kaur
Amritpal Kaur
PSPargat Singh
Pargat Singh
GLGagan Deep Longowal
Gagan Deep Longowal
SASandeep Arora
Sandeep Arora
Background: Breast Cancer (BC) is the most widely recognized disease in women. A massive number of women are diagnosed with breast cancer and many lost their lives every year. Cancer is the subsequent driving reason for dying, giving rise to it one of the current medication's most prominent difficulties. Objectives: The main objective of the study is to examine and explore novel therapy (PROTAC) and its effectiveness against breast cancer. Methods: The literature search was done across Medline, Cochrane, ScienceDirect, Wiley Online, Google Scholar, PubMed, Bentham Sciences from 2001 to 2020. The articles were collected; screened, segregated, and selected papers were included for writing the review article. Results and Conclusion: A novel innovation emerged around two decades ago that has great potential to not only overcome the limitations but also can provide future direction for the treatment of many diseases which has presently not many therapeutic options available and regarded as incurable with traditional techniques; that innovation is called PROTAC (Proteolysis Targeting Chimera) and able to efficaciously ubiquitinate and debase cancer encouraging proteins by noncovalent interaction. PROTACs are constituted of two active regions isolated by a linker and equipped for eliminating explicit undesirable protein. It is empowering greater sensitivity to "drug-resistant targets" as well as a more prominent opportunity to influence non-enzymatic function. PROTACs have been demonstrated to show better target selectivity contrasted with traditional small-molecule inhibitors. So far, the most investigation into PROTACs possesses particularly concentrated on applications to cancer treatment including breast cancer, the treatment of different ailments may profit from this blossoming innovation.